A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation

Endocrine-Related Cancer

Volumn 20, Issue 4, 2013, Pages 515-525

  Armstrong, Cameron M ^a   Billimek, Autumn R ^a   Allred, Kimberly F ^a   Sturino, Joseph M ^a   Weeks, Brad R ^b   Allred, Clinton D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Colon cancer; Estradiol; Estrogen receptor ; Estrogen receptor ; Inflammation

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; COLON TUMOR; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; EPITHELIUM CELL; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

COLON CANCER; ESTRADIOL; ESTROGEN RECEPTOR Α; ESTROGEN RECEPTOR Β; INFLAMMATION;

ANIMALS; ANTINEOPLASTIC AGENTS; AZOXYMETHANE; COLONIC NEOPLASMS; DEXTRAN SULFATE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84882772276     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0308     Document Type: Article

References (37)

1. Armstrong CM, Allred KF & Allred CD 2011 Dietary fish oil reduces DNA adduct formation while estradiol upregulates apoptosis in response to DNA damage in the rat colon. Digestive Diseases and Sciences 56 2585-2594. (doi:10.1007/s10620-011-1667-1)
2. Bernstein CN, Blanchard JF, Kliewer E & Wajda A 2001 Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 854-862. (doi:10.1002/1097-0142(20010215)91:4〈854::AID-CNCR1073〉3.0. CO;2-Z)
3. Brekman A, Singh KE, Polotskaia A, Kundu N & Bargonetti J 2011 A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Research 13 R3. (doi:10.1186/bcr2804)
4. Castiglione F, Taddei A, Degl'Innocenti DR, Buccoliero AM, Bechi P, Garbini F, Chiara FG, Moncini D, Cavallina G, Marascio L et al. 2008 Expression of estrogen receptor b in colon cancer progression. Diagnostic Molecular Pathology 17 231-236. (doi:10.1097/PDM.0b013e3181656d67)
5. Castoria G, Migliaccio A, Giovannelli P & Auricchio F 2010 Cell proliferation regulated by estradiol receptor: therapeutic implications. Steroids 75 524-527. (doi:10.1016/j.steroids.2009.10.007)
6. Chisamore MJ, Wilkinson HA, Flores O & Chen JD 2009 Estrogen-related receptor-α antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Molecular Cancer Therapeutics 8 672-681. (doi:10.1158/1535-7163. MCT-08-1028)
7. Cho NL, Javid SH, Carothers AM, Redston M & Bertagnolli MM 2007 Estrogen receptors a and b are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Research 67 2366-2372. (doi:10.1158/0008-5472.CAN-06-3026)
8. Cleveland AG, Oikarinen SI, Bynote KK, Marttinen M, Rafter JJ, Gustafsson JA, Roy SK, Pitot HC, Korach KS, Lubahn DB et al. 2009 Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice. Carcinogenesis 30 1581-1590. (doi:10.1093/carcin/bgp132)
9. Delellis Henderson K, Duan L, Sullivan-Halley J, Ma H, Clarke CA, Neuhausen SL, Templeman C & Bernstein L 2010 Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. American Journal of Epidemiology 171 415-425. (doi:10.1093/aje/kwp434)
10. Di Leo A, Barone M, Maiorano E, Tanzi S, Piscitelli D, Marangi S, Lofano K, Ierardi E, Principi M & Francavilla A 2008 ER-b expression in large bowel adenomas: implications in colon carcinogenesis. Digestive and Liver Disease 40 260-266. (doi:10.1016/j.dld.2007.10.018)
11. Eaden JA, Abrams KR & Mayberry JF 2001 The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 526-535. (doi:10.1136/gut.48.4. 526)
12. Goh HS, Yao J & Smith DR 1995 p53 point mutation and survival in colorectal cancer patients. Cancer Research 55 5217-5221.
13. Guo JY, LiX, Browning JD, Jr, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M & MacDonald RS 2004 Dietary soy isoflavones and estrone protect ovariectomized ERaKO and wild-type mice from carcinogen-induced colon cancer. Journal of Nutrition 134 179-182.
14. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE et al. 2008 Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Journal of the American Medical Association 299 1036-1045. (doi:10.1001/jama.299.9.1036)
15. Hoffmeister M, Raum E, Krtschil A, Chang-Claude J & Brenner H 2009 No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clinical Pharmacology and Therapeutics 86 416-424. (doi:10.1038/clpt.2009.134)
16. Jiang H, Teng R, Wang Q, Zhang X, Wang H, Wang Z, Cao J & Teng L 2008 Transcriptional analysis of estrogen receptor a variant mRNAs in colorectal cancers and their matched normal colorectal tissues. Journal of Steroid Biochemistry and Molecular Biology 112 20-24. (doi:10.1016/j.jsbmb.2008.07.004)
17. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G & Papavassiliou AG 2003 Oestrogen receptor b (ERb) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. European Journal of Cancer 39 1251-1258. (doi:10.1016/S0959-8049(03)00239-9)
18. Lakatos PL 2006 Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World Journal of Gastroenterology 12 6102-6108. (Pubitemid 44688157)
19. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Norgard B & Sorensen HT 2007 Survival after colorectal cancer in patients with Crohn's disease: a nationwide population-based Danish follow-up study. American Journal of Gastroenterology 102 163-167. (doi:10.1111/j.1572-0241.2006.00857.x)
20. Lenton EA, Sulaiman R, Sobowale O & Cooke ID 1982 The human menstrual cycle: plasma concentrations of prolactin, LH, FSH, oestradiol and progesterone in conceiving and non-conceiving women. Journal of Reproduction and Fertility 65 131-139. (doi:10.1530/jrf.0.0650131)
21. Lof M, Hilakivi-Clarke L, Sandin SS, de Assis S, Yu W & Weiderpass E 2009 Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Women's Health 9 10. (doi:10.1186/1472-6874-9-10)
22. Mellemkjaer L, Johansen C, Gridley G, Linet MS, Kjaer SK & Olsen JH 2000 Crohn's disease and cancer risk (Denmark). Cancer Causes & Control 11 145-150. (doi:10.1023/A:1008988215904)
23. Mostafaie N, Kallay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR & Krugluger W 2009 Correlated downregulation of estrogen receptor β and the circadian clock gene Per1 in human colorectal cancer. Molecular Carcinogenesis 48 642-647. (doi:10.1002/mc.20510)
24. Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN & Potter JD 2007 Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Research 67 7534-7539. (doi:10.1158/0008-5472.CAN-06-4275)
25. Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN & Henderson BE 2000 Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. British Journal of Cancer 82 1867-1870. (doi:10.1054/bjoc.1999.1082)
26. Rasmussen LM, Frederiksen KS, Din N, Galsgaard E, Christensen L, Berchtold MW & Panina S 2010 Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells. Endocrine-Related Cancer 17 809-822. (doi:10.1677/ERC-09-0326)
27. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333. (doi:10.1001/jama.288.3.321)
28. Rudolph A, Toth C, Hoffmeister M, Roth W, Herpel E, Jansen L, Marx A, Brenner H & Chang-Claude J 2012 Expression of oestrogen receptor β and prognosis of colorectal cancer. British Journal of Cancer 107 831-839. (doi:10.1038/bjc.2012.323)
29. Saleiro D, Murillo G, Benya RV, Bissonnette M, Hart J & Mehta RG 2012 Estrogen receptor-b protects against colitis-associated neoplasia in mice. International Journal of Cancer 131 2553-2561. (doi:10.1002/ijc.27578)
30. Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell FA & Prentice RL 2012 Estrogen plus progestin and colorectal cancer incidence and mortality. Journal of Clinical Oncology 30 3983-3990. (doi:10.1200/JCO.2012.42.7732)
31. Smirnoff P, Liel Y, Gnainsky J, Shany S & Schwartz B 1999 The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncology Research 11 255-264.
32. Soderlund S, Granath F, Brostrom O, Karlen P, Lofberg R, Ekbom A & Askling J 2010 Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology 138 1697-1703. (doi:10.1053/j.gastro.2010.02.007)
33. Truan JS, Chen JM & Thompson LU 2010 Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen. Molecular Nutrition & Food Research 54 1414-1421. (doi:10.1002/mnfr.200900521)
34. Weige CC, Allred KF & Allred CD 2009 Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Research 69 9118-9124. (doi:10.1158/0008-5472.CAN-09-2348)
35. Weige CC, Allred KF, Armstrong CM & Allred CD 2012 P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes. Journal of Steroid Biochemistry and Molecular Biology 128 113-120. (doi:10.1016/j.jsbmb.2011.10.010)
36. Wood GA, Fata JE, Watson KL & Khokha R 2007 Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction 133 1035-1044. (doi:10.1530/REP-06-0302)
37. Wu AH, Siegmund KD, Long TI, Cozen W, Wan P, Tseng CC, Shibata D & Laird PW 2010 Hormone therapy, DNA methylation and colon cancer. Carcinogenesis 31 1060-1067. (doi:10.1093/carcin/bgq009)